Skip to main content



09-10-2020 | Rheumatology | News | Article

Early data show benefits of romilkimab in diffuse cutaneous SSc

Romilkimab could significantly improve skin fibrosis in people with early diffuse cutaneous systemic sclerosis, results of a phase 2 proof-of-concept study suggest.

30-07-2019 | Rheumatology | News | Article

Abatacept fails to improve skin disease in SSc trial

Findings from the phase II ASSET trial suggest that patients with diffuse cutaneous systemic sclerosis who are treated with abatacept do not experience significantly greater improvements in skin disease than those given placebo.

16-08-2018 | Skin cancer | News | Article

Brief dermatologist-delivered intervention may improve sun protection behavior

The Addressing Behavior Change intervention, which can be delivered by dermatologists in less than 3 minutes, is associated with improvements in people’s sun protection behavior that last several months, findings indicate.

06-08-2018 | Oncology | News | Article

Delayed onset of PD-1-associated cutaneous reactions reported

Cutaneous adverse reactions resulting from programmed cell death protein 1 inhibitor therapy can occur late after treatment initiation or even after discontinuation, according to findings reported in JAMA Dermatology.

08-06-2018 | Rheumatology | News | Article

DISCONNECT between patient- and physician-perceived impact of PsA symptoms

Researchers have identified discrepancies between patient and physician perspectives of bother associated with the different symptoms of psoriatic disease.

09-01-2018 | Melanoma | News | Article

Pembrolizumab discontinuation feasible in metastatic melanoma

Patients with metastatic melanoma who achieve a complete response with pembrolizumab therapy have a low risk for disease progression or death, report researchers who believe that treatment discontinuation is possible in this setting.

15-04-2016 | Oncology | News | Article

EZH2 potential target in cutaneous basal cell carcinoma

The expression of the histone methyltransferase EZH2 correlates with aggressive subtypes of cutaneous basal cell carcinoma, highlighting the possibility that EZH2 may be an actionable target in this malignancy, say researchers.

07-04-2016 | Lymphoma | News | Article

APO866 lacks efficacy in cutaneous T-cell lymphoma

The nicotinamide adenine dinucleotide biosynthesis inhibitor APO866 does not show efficacy in patients with cutaneous T-cell lymphoma, according to phase II trial results reported in JAMA Dermatology.

27-01-2016 | Oncology | News | Article

Sirolimus chemoprevention supported in organ transplant recipients

In solid-organ transplant recipients (OTRs) diagnosed with cancer post-transplant, treatment with sirolimus reduces the risk of developing a subsequent skin cancer, US investigators report in JAMA Dermatology.

22-05-2015 | Chronic myeloid leukaemia | News | Article

Skin Cancer Awareness Recommended For HCT Recipients

Patients who undergo haematopoietic cell transplantation should be educated on the risk of skin cancer and the need for regular self-examination, US researchers say.

25-04-2013 | General practice | Article

Skin cancer may increase subsequent primary malignancy risk

Research suggests that people with non-melanoma skin cancer are at moderately increased risk for developing other primary malignancies in the future, particularly breast and lung cancer and melanoma.

22-04-2013 | Immunology | Article

Single allergen sensitization tests may miss cases in children

There is significant discordance between the results of allergen-specific skin prick tests and allergen-specific serum immunoglobulin E levels for identifying aeroallergen sensitization in children under the age of 4 years, a study finds.

18-04-2013 | Genetics | Article

FOXP3 gene genetic variants linked with vitiligo

Three variants in the forkhead box P3 gene are associated with increased risk for vitiligo in the Han Chinese population, show study findings.

11-04-2013 | General practice | Article

Follicular squamous cell carcinoma rates ‘underestimated’

Rates of follicular squamous cell carcinomas are underestimated, suggest results from a study published in the British Journal of Dermatology.

04-04-2013 | General practice | Article

Factors predicting progressive disease in melanoma patients investigated

Demographic, clinical, and procedural factors should not be used to predict the likelihood of progression after regional therapy for “in-transit” or early metastatic melanoma, say researchers.

21-03-2013 | Immunology | Article

Scabies link with pemphigoid investigated

Research suggests that patients who experience scabies infection may be at increased risk for developing the autoimmune blistering skin condition bullous pemphigoid.

21-03-2013 | Metabolism | Article

Psoriasis a risk factor for diabetes, cardiovascular disease

Patients with psoriasis are at an increased risk for developing diabetes and cardiovascular disease, report researchers.

20-03-2013 | Podiatry | Article

Green tea extract washes athlete’s foot symptoms away

Bathing feet in a green tea extract may help relieve skin symptoms in elderly patients with athlete’s foot, say Japanese researchers.

14-03-2013 | Dermatology | Article

Nutritional factors linked to psoriasis risk

Psoriasis is significantly linked to increased serum vitamin A and alpha-carotene levels, as well as reduced sugar intake, say US scientists.

10-03-2013 | Immunology | Article

Rituximab may provide functional cure for pemphigus

Rituximab can induce long-term complete remission in patients with the chronic autoimmune disease pemphigus, show study findings.